Search reports.
Chenodeoxycholic Acid Market Share, Growth & Forecast [2031]
Get free sample report Request for Customiztion Buy Now

Chenodeoxycholic Acid Market Share, Growth & Forecast [2031]

Segments - Chenodeoxycholic Acid Market by Applications (Emulsifier, Organic Acid, Medicine, Detergents, and Others) and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031.

https://growthmarketreports.com/Riddhesh
Author : Riddhesh Dani
https://growthmarketreports.com/Harneet
Fact-checked by : Harneet Meher
https://growthmarketreports.com/Shruti
Editor : Shruti Bhat

Upcoming | Report ID :MC-4372 | 4.8 Rating | 70 Reviews | 157 Pages | Format : PDF Excel PPT

Report Description


The global chenodeoxycholic acid market size was USD XX Billion in 2022 and is likely to reach USD XX Billion by 2031, expanding at a CAGR of 6.8% during the forecast period, 2023–2031. The growth of the market is attributed to increasing demand for emulsifiers, organic acids, pharmaceuticals, and detergents in a variety of businesses throughout the world.

Chenodeoxycholic Acid Market Outlook

Chenodeoxycholic acid (CDCA) is a bile acid that is spontaneously created by the human liver and stored in the gall bladder until needed for dietary fat absorption. It is used to treat bile synthesis abnormalities caused by single enzyme deficiencies, peroxisomal diseases, and Zellweger syndrome. Oral bile acid treatment has been utilized in individuals with tiny cholesterol stones as well as those with bigger cholesterol gallstones who are unable or unwilling to perform the surgery.

However, CDCA causes diarrhea when it is used to dissolve gallstones, it has been explored as a potential therapy for constipation and has been found to enhance colonic transit and bowel function. Moreover, Giaconda, an Australian biotechnology company, has tested a Hepatitis C medication that combines chenodeoxycholic acid and bezafibrate.

New severe acute respiratory syndrome that is coronavirus disease has generated an unparalleled worldwide public health disaster. COVID-19 outbreak has three key implications on the global economy: disruption of supply chains and marketplaces, direct influence on production and demand, and financial impact on enterprises and financial markets.

  • Growing demand for cholagogues and PSC drugs drives market during the forecast period.
  • Rising population in developing countries such as China & India likely to propel the market expansion.
  • Increasing number of gall stone cases throughout the world due to different factors such as obesity, hereditary disorders, and other medical diseases anticipated to boost the market growth.
  • Cholic acid and related medications taken in excess can produce jaundice, which can lead to severe liver damage. This is projected to hinder market expansion in the coming years.
  • CDCA is a natural substance with a short patent life in most places, resulting in limited availability and high costs for drug development. This is a major factor which hamper the market.
  • Demand from food & beverage industries and pharmaceuticals anticipated to create lucrative opportunities for the market growth during the forecast period.

Scope of Chenodeoxycholic Acid Market Report

The report on the global chenodeoxycholic acid market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Chenodeoxycholic Acid Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Applications (Emulsifier, Organic Acid, Medicine, Detergents, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Tianjin NWS Biotechnology and Medicine; Shaanxi Top Pharm Chemical; Pharmazell; Haihang Industry; Dr Falk Pharma; Daewoong; Bruschettini; Suzhou Tianlu Bio-Pharmaceutical; and Zhongshan Belling Biotechnology

Chenodeoxycholic Acid Market Segment Insights

Organic Acid segment to expand at a considerable CAGR

On the basis of applications, the chenodeoxycholic acid market is segmented into emulsifier, organic acid, medicine, detergents, and others. The organic acid segment is projected to expand at a considerable CAGR during the forecast period, due to the high demand in food & beverages, textile industries, and pharmaceuticals. On the other hand, the emulsifier segment is anticipated to account for a major market share during the forecast period. The emulsifier agents have great demand in cosmetic industry as to form the emulsion.

Chenodeoxycholic Acid Market Applications

Europe is anticipated to constitute a key market share

In terms of regions, the chenodeoxycholic acid market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Europe is expected to constitute a key share of the market during the projected period owing to high production of cholic acid. The region's huge number of manufacturers will help to drive regional market expansion. However, the market of Asia Pacific is anticipated to expand at a rapid pace during the forecast period due to increasing incidence of kidney failure, gallstones, and other kidney-related diseases.
                                 

Chenodeoxycholic Acid Market Region

Segments

The global chenodeoxycholic acid market has been segmented on the basis of

Applications

  • Emulsifier
  • Organic Acid
  • Medicine
  • Detergents
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Tianjin NWS Biotechnology and Medicine
  • Shaanxi Top Pharm Chemical
  • Pharmazell
  • Haihang Industry
  • Dr Falk Pharma
  • Daewoong
  • Bruschettini
  • Suzhou Tianlu Bio-Pharmaceutical
  • Zhongshan Belling Biotechnology

Competitive Landscape

Key players competing in the chenodeoxycholic acid market are Tianjin NWS Biotechnology and Medicine; Shaanxi Top Pharm Chemical; Pharmazell; Haihang Industry; Dr Falk Pharma; Daewoong; Bruschettini; Suzhou Tianlu Bio-Pharmaceutical; and Zhongshan Belling Biotechnology

The market is extremely fragmented due to the existence of a significant number of global and local competitors. Furthermore, international businesses' consolidation actions are expected to boost rivalry among emerging and local market competitors. The market's top companies are always striving to expand their market share.

Chenodeoxycholic Acid Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Chenodeoxycholic Acid Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Chenodeoxycholic Acid Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Chenodeoxycholic Acid Market - Supply Chain
  4.5. Global Chenodeoxycholic Acid Market Forecast
     4.5.1. Chenodeoxycholic Acid Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Chenodeoxycholic Acid Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Chenodeoxycholic Acid Market Absolute $ Opportunity
5. Global Chenodeoxycholic Acid Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. Chenodeoxycholic Acid Market Size and Volume Forecast by Applications
     5.3.1. Emulsifier
     5.3.2. Organic Acid
     5.3.3. Medicine
     5.3.4. Detergents
     5.3.5. Others
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Chenodeoxycholic Acid Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Chenodeoxycholic Acid Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Chenodeoxycholic Acid Demand Share Forecast, 2019-2026
7. North America Chenodeoxycholic Acid Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Chenodeoxycholic Acid Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Chenodeoxycholic Acid Market Size and Volume Forecast by Applications
     7.4.1. Emulsifier
     7.4.2. Organic Acid
     7.4.3. Medicine
     7.4.4. Detergents
     7.4.5. Others
  7.5. Basis Point Share (BPS) Analysis by Applications
  7.6. Y-o-Y Growth Projections by Applications
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Chenodeoxycholic Acid Demand Share Forecast, 2019-2026
8. Latin America Chenodeoxycholic Acid Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Chenodeoxycholic Acid Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Chenodeoxycholic Acid Market Size and Volume Forecast by Applications
     8.4.1. Emulsifier
     8.4.2. Organic Acid
     8.4.3. Medicine
     8.4.4. Detergents
     8.4.5. Others
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Chenodeoxycholic Acid Demand Share Forecast, 2019-2026
9. Europe Chenodeoxycholic Acid Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Chenodeoxycholic Acid Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Chenodeoxycholic Acid Market Size and Volume Forecast by Applications
     9.4.1. Emulsifier
     9.4.2. Organic Acid
     9.4.3. Medicine
     9.4.4. Detergents
     9.4.5. Others
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Chenodeoxycholic Acid Demand Share Forecast, 2019-2026
10. Asia Pacific Chenodeoxycholic Acid Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Chenodeoxycholic Acid Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Chenodeoxycholic Acid Market Size and Volume Forecast by Applications
     10.4.1. Emulsifier
     10.4.2. Organic Acid
     10.4.3. Medicine
     10.4.4. Detergents
     10.4.5. Others
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Chenodeoxycholic Acid Demand Share Forecast, 2019-2026
11. Middle East & Africa Chenodeoxycholic Acid Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Chenodeoxycholic Acid Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Chenodeoxycholic Acid Market Size and Volume Forecast by Applications
     11.4.1. Emulsifier
     11.4.2. Organic Acid
     11.4.3. Medicine
     11.4.4. Detergents
     11.4.5. Others
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Chenodeoxycholic Acid Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Chenodeoxycholic Acid Market: Market Share Analysis
  12.2. Chenodeoxycholic Acid Distributors and Customers
  12.3. Chenodeoxycholic Acid Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Tianjin NWS Biotechnology and Medicine
     12.4.2. Shaanxi Top Pharm Chemical
     12.4.3. Pharmazell
     12.4.4. Haihang Industry
     12.4.5. Dr Falk Pharma
     12.4.6. Daewoong
     12.4.7. Bruschettini
     12.4.8. Suzhou Tianlu Bio-Pharmaceutical
     12.4.9. Zhongshan Belling Biotechnology

Methodology

Our Clients

FedEx Logistics
Dassault Aviation
Nestle SA
Honda Motor Co. Ltd.
Siemens Healthcare
General Electric
Pfizer
Deloitte